Self-adjuvanting multicomponent cancer vaccine candidates co…
Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.
Article, Chapter
Full text availability for this item
Coverage:
- 1998-02-02~present; volume:37~present
Coverage:
- 1998~present; volume:37~present